Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Heart Failure 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Postoperative Complications 1Pheochromocytoma 1Pain, Postoperative 1Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Jaw Cysts 1Gastrointestinal Stromal Tumors 1Arrhythmias, Cardiac 1Agnosia 1

Interventions

Temozolomide 5anlotinib 43-Iodobenzylguanidine 4lutetium Lu 177 dotatate 3Specimen Handling 3cabozantinib 2belzutifan 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Everolimus 2Axitinib 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2tipifarnib 1talazoparib 1penpulimab 1pembrolizumab 1pazopanib 1olaparib 1lenvatinib 1lanreotide 1guadecitabine 1gallium Ga 68 dotatate 1fostamatinib 1copper dotatate CU-64 1atezolizumab 1Tamoxifen 1Sunitinib 1Ritonavir 1Octreotide 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pheochromocytoma × Control Groups × Clear all
NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡